Roundtable: “When Incentives Meet Information” with Bryan Roberts, February 11 (Virtual)
The Virtual Healthcare Roundtables are monthly sessions that provide timely discussions with leaders in the industry.
Q: What Happens When Incentives Meet
Information in Healthcare?
A: "Capitalism gets a second chance." - Bryan Roberts, Partner at Venrock
Capitalism and free market forces, the bedrocks of US
economic success, have rarely been seen in our country’s largest industry –
Healthcare. We are all familiar with the failings in cost and outcomes that is
the multi-headed hydra that is the patient – payer – provider ecosystem. Costs
increase faster than GDP, while wages for physicians fall. Administrative
personnel now number an amazing 16 per MD. The examples go on and on. However,
the last five years have witnessed the beginnings of change as the twin forces
of incentives and information combine to dramatically reshape the workings of
our healthcare system. Entrepreneurs have realized this opportunity and are
seizing it across many dimensions in HC – it is fascinating, exciting and still
in its infancy.
note that registration closes one hour prior to the session.
Date: Tuesday, February 11, 2014
Time: 12:00 noon - 1:00 pm ET
Location: Virtual. Dial-in information will be sent the evening prior to
Cost: FREE for members; $25 non-members
Bryan joined Venrock as a Kauffman Fellow in
1997. He is based in Venrock’s Palo Alto office and focuses on a broad range
of healthcare investments. Bryan is currently Chairman of the Board of
Directors of Achaogen, Castlight Health, and Ironwood Pharmaceuticals
(NASDAQ: IRWD), in addition to serving on the Board of several other private
companies. Past investments include athenahealth (NASDAQ: ATHN), Illumina
(NASDAQ: ILMN) and Sirna Therapeutics (acquired by Merck). Bryan was named a
Henry Crown Fellow by the Aspen Institute in 2006 and has been the
highest-ranking healthcare investor on Forbes’ Midas List
Immediately prior to joining Venrock, Bryan
received his PhD in Chemistry & Chemical Biology from Harvard University.
He previously held positions in corporate finance at Kidder, Peabody & Co
and received his BA from Dartmouth College.